BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 23259781)

  • 1. Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma.
    Qi J; Wang J; Katayama H; Sen S; Liu SM
    Neoplasma; 2013; 60(2):135-42. PubMed ID: 23259781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
    Zhang YC; Xu Z; Zhang TF; Wang YL
    World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China.
    Jiang L; Cheng Q; Zhang BH; Zhang MZ
    Medicine (Baltimore); 2015 Mar; 94(10):e603. PubMed ID: 25761179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of microRNAs for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
    He S; Hu XW; Wang D; Han LF; Zhang DC; Wei C
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):405-17. PubMed ID: 27016891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.
    Zhang C; Xia R; Zhang B; Wang H
    BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers.
    Mirzaei HR; Sahebkar A; Mohammadi M; Yari R; Salehi H; Jafari MH; Namdar A; Khabazian E; Jaafari MR; Mirzaei H
    Curr Pharm Des; 2016; 22(34):5257-5269. PubMed ID: 26935703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs for the diagnosis of hepatocellular carcinoma.
    Peng C; Ye Y; Wang Z; Guan L; Bao S; Li B; Li W
    Dig Liver Dis; 2019 May; 51(5):621-631. PubMed ID: 30744930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis.
    Li G; Shen Q; Li C; Li D; Chen J; He M
    Clin Transl Oncol; 2015 Sep; 17(9):684-93. PubMed ID: 25956842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma.
    Bhattacharya S; Steele R; Shrivastava S; Chakraborty S; Di Bisceglie AM; Ray RB
    Am J Pathol; 2016 Feb; 186(2):242-7. PubMed ID: 26776075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma.
    Dhayat SA; Hüsing A; Senninger N; Schmidt HH; Haier J; Wolters H; Kabar I
    PLoS One; 2015; 10(10):e0140066. PubMed ID: 26447841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
    Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
    Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs as biomarkers for hepatocellular carcinoma diagnosis and prognosis.
    He S; Zhang DC; Wei C
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):426-34. PubMed ID: 25746139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
    Jin Y; Wong YS; Goh BKP; Chan CY; Cheow PC; Chow PKH; Lim TKH; Goh GBB; Krishnamoorthy TL; Kumar R; Ng TP; Chong SS; Tan HH; Chung AYF; Ooi LLPJ; Chang JPE; Tan CK; Lee CGL
    Sci Rep; 2019 Jul; 9(1):10464. PubMed ID: 31320713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma.
    An Y; Gao S; Zhao WC; Qiu BA; Xia NX; Zhang PJ; Fan ZP
    World J Gastroenterol; 2018 Jun; 24(24):2596-2604. PubMed ID: 29962816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
    Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
    World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
    PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
    Lin L; Lu B; Yu J; Liu W; Zhou A
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison.
    Shen S; Lin Y; Yuan X; Shen L; Chen J; Chen L; Qin L; Shen B
    Sci Rep; 2016 Dec; 6():38311. PubMed ID: 27917899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma.
    Zhuang L; Xu L; Wang P; Meng Z
    PLoS One; 2015; 10(2):e0117274. PubMed ID: 25642945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum miRNAs as predictive and preventive biomarker for pre-clinical hepatocellular carcinoma.
    Li L; Chen J; Chen X; Tang J; Guo H; Wang X; Qian J; Luo G; He F; Lu X; Ding Y; Yang Y; Huang W; Hou G; Lin X; Ouyang Q; Li H; Wang R; Jiang F; Pu R; Lu J; Jin M; Tan Y; Gonzalez FJ; Cao G; Wu M; Wen H; Wu T; Jin L; Chen L; Wang H
    Cancer Lett; 2016 Apr; 373(2):234-40. PubMed ID: 26850373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.